These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2285533)

  • 41. Antineutrophil cytoplasmic antibodies and their relevance to the dermatologist.
    Burrows NP; Lockwood CM
    Br J Dermatol; 1995 Feb; 132(2):173-81. PubMed ID: 7888354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The nosology of Wegener's granulomatosis utilizing the elk format augmented by c-ANCA.
    DeRemee RA
    Adv Exp Med Biol; 1993; 336():209-15. PubMed ID: 8296609
    [No Abstract]   [Full Text] [Related]  

  • 43. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
    Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B
    Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of autoantibodies to purified proteinase 3 in systemic vasculitis.
    Gaskin G; Turner AN; Ryan JJ; Rees AJ; Pusey CD
    Adv Exp Med Biol; 1993; 336():287-9. PubMed ID: 8296619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
    van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
    Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA).
    Selak S; Woodman RC; Fritzler MJ
    Clin Exp Immunol; 2000 Dec; 122(3):493-8. PubMed ID: 11122260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and other diseases: clinical issues.
    Galperin C; Hoffman GS
    Cleve Clin J Med; 1994; 61(6):416-27. PubMed ID: 7828332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis.
    Wiik A
    Clin Exp Rheumatol; 1993; 11(2):191-201. PubMed ID: 8508563
    [No Abstract]   [Full Text] [Related]  

  • 49. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
    Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
    Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-neutrophil cytoplasmic antibodies (ANCA) and renal diseases.
    Savige JA
    Aust N Z J Med; 1995 Feb; 25(1):40-1. PubMed ID: 7786244
    [No Abstract]   [Full Text] [Related]  

  • 51. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA.
    Mulder AH; Stegeman CA; Kallenberg CG
    Clin Exp Immunol; 1995 Aug; 101(2):227-32. PubMed ID: 7648707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated initial serum creatinine in Wegener's granulomatosis with anti-myeloperoxidase autoantibodies.
    Lai MY; Lin CC; Ng YY; Yang WC
    Kidney Int; 2006 Apr; 69(7):1281. PubMed ID: 16609690
    [No Abstract]   [Full Text] [Related]  

  • 53. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis.
    Holland M; Takada K; Okumoto T; Takahashi N; Kato K; Adu D; Ben-Smith A; Harper L; Savage CO; Jefferis R
    Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible pathogenetic implications of ANCA in vasculitic syndromes.
    van der Woude FJ
    APMIS Suppl; 1990; 19():29-30. PubMed ID: 2285534
    [No Abstract]   [Full Text] [Related]  

  • 55. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis.
    Wong SN; Shah V; Dillon MJ
    Arch Dis Child; 1998 Sep; 79(3):246-50. PubMed ID: 9875021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new approach to the molecular characterization of the c-ANCA antigen in Wegener's granulomatosis.
    Bleil L; Winkler TH; Fehr HK; Bautz EK; Kalden JR
    Adv Exp Med Biol; 1993; 336():51-4. PubMed ID: 8296666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wegener's granulomatosis, subglottic stenosis and antineutrophil cytoplasm antibodies.
    Hoare TJ; Jayne D; Rhys Evans P; Croft CB; Howard DJ
    J Laryngol Otol; 1989 Dec; 103(12):1187-91. PubMed ID: 2693566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wegener's granulomatosis presenting as pulmonary metastases: value of antineutrophil cytoplasmic antibodies in diagnosis.
    Davies MJ; Hall DR
    Respir Med; 1990 Jul; 84(4):339-40. PubMed ID: 2236762
    [No Abstract]   [Full Text] [Related]  

  • 59. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders.
    Tervaert JW; Mulder L; Stegeman C; Elema J; Huitema M; The H; Kallenberg C
    Ann Rheum Dis; 1993 Feb; 52(2):115-20. PubMed ID: 8383482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulfamethoxazole-trimethoprim (SMZ-TMP) as an effective therapy for Wegener's granulomatosis (WG)--three more cases.
    Hoen B; Aymard B; Gerard A; Brunet A; Mertes PM; May T; Canton P; Dureux JB
    APMIS Suppl; 1990; 19():65. PubMed ID: 2285545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.